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ABSTRACT Surfactant protein SP-B is absolutely required for the surface activity of pulmonary surfactant and postnatal lung
function. The results of a previous study indicated that the N-terminal segment of SP-B, comprising residues 1–9, is speciﬁcally
required for surface activity, and suggested that prolines 2, 4, and 6 as well as tryptophan 9, may constitute essential structural
motifs for protein function. In this work, we assessed the role of these two motifs in promoting the formation and maintenance of
surface-active ﬁlms. Three synthetic peptides were synthesized including a peptide corresponding to the N-terminal 37 amino
acids of native SP-B and two variants in which prolines 2, 4, 6, or tryptophan 9 were substituted by alanines. All three synthetic
peptides were surface-active, as expected from their amphipathic structure. The peptides were also able to insert into
dipalmitoylphosphatidylcholine/palmitoyloleoylphosphatidylglycerol (7:3 w/w ratio) monolayers preformed at pressures .30
mN/m, indicating that they perturb and insert into membranes. Substitution of alanine for tryptophan at position 9 signiﬁcantly
decreased both the rate of adsorption/insertion of the peptide into the interface and reinsertion of surface-active material
excluded from the ﬁlm during successive compression-expansion cycles. Substitution of alanines for prolines at positions 2, 4,
and 6 did not produce substantial changes in the rate of adsorption/insertion; however, reinsertion of surface-active material into
the expanding interface ﬁlm was not as effective as in the presence of the nativelike peptide. These results suggest that W9 is
critical for optimal interface afﬁnity, whereas prolines may promote a conformation that facilitates rapid insertion of the peptide
into phospholipid monolayers compressed to the highest pressures during compression-expansion cycling.
INTRODUCTION
Surfactant protein B (SP-B), a very hydrophobic polypeptide
of 79 amino acids, plays a critical role in the organization and
function of pulmonary surfactant (1). Surfactant is a lipid-
protein complex secreted by type II pneumocytes into the
thin aqueous layer that covers the alveoli where it sponta-
neously adsorbs to the air-water interface. The surfactant ﬁlm
reduces surface tension to values close to 0 mN/m at end
expiration, thereby preventing alveolar collapse. The lipid
fraction of surfactant, which contains ;40% dipalmitoyl-
phosphocholine (DPPC) and 10% phosphatidylglycerol
(PG), is directly responsible for the surface-active function;
however, efﬁcient formation and maintenance of a surfactant
ﬁlm during successive compression-expansion cycles re-
quires the presence of SP-B or another hydrophobic sur-
factant protein, SP-C. Genetic deﬁciency of SP-B in both
humans and mice causes lethal respiratory failure at birth
(2,3), demonstrating that this peptide is absolutely required
for lung function. In contrast, genetic deﬁciency of SP-C in
mice is not associated with neonatal respiratory failure (4).
Premature infants presenting with lung immaturity often
develop neonatal respiratory distress syndrome arising from
surfactant deﬁciency, elevated surface tension, and alveolar
collapse. Prompt treatment with an exogenous surfactant
preparation containing surfactant lipids and SP-B and/or SP-
C can rapidly restore lung function in premature infants. SP-
B is required for postnatal lung function and survival (5,6)
and SP-B concentration is decreased in some patients with
acute respiratory distress syndrome (7). Therefore, it can be
anticipated that SP-B, or a functional analog of the protein,
will be an important component of a surfactant therapy for
treatment of acute respiratory distress syndrome. Because
there is currently no expression system capable of producing
a recombinant peptide similar to native SP-B, a detailed
study of the structure-function relationships of the protein is
important to deﬁne the minimal structural determinants able
to mimic SP-B functions in a synthetic peptide.
SP-B is isolated from alveolar airspaces as an homodimer
that is stabilized by an intermolecular disulphide bridge.
Three intramolecular disulphide bridges are present in each
monomer, revealing the disulphide bond pattern typical of all
saposin-like proteins (8). Members of this family include
amoebapores, sulphated glycoprotein-1, acyloxyacylhydro-
lase, acid sphingomyelinase, the sphingolipid-activating pro-
teins (saposins), andNK-lysin, for which the three-dimensional
structure has been determined by NMR (9). All of these
proteins transiently interact with lipids but their functions in
vivo are quite varied. SP-B is very hydrophobic, and is the
only saposin-like protein that is always lipid-associated. The
structure and lipid binding properties of SP-B have been ex-
tensively studied using different techniques (10–13). Al-
though the three-dimensional structure of SP-B is still not
known, several studies have suggested that SP-B interacts
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with lipids via four or ﬁve amphipathic a-helices (14,15).
This interaction leads to fusion and lysis of lipid vesicles
(16–18), activities that might be critical for packaging of
surfactant phospholipids in the exocytic pathway of type II
pneumocytes. SP-B-mediated fusion and lysis may also play
an important role in the formation and maintenance of the
surface ﬁlm and the closely linked reservoir of surfactant
material extended underneath (19). The potential importance
of these particular SP-B properties in surfactant membrane
transitions has recently been addressed by Ryan and co-
workers (20). Synthetic peptides were used to map the
fusogenic and lytic activities of the protein, and assess the
requirement of these properties for SP-B surface activity.
The results suggested that the fusogenic, lytic, and surface
activities of SP-B mapped predominantly to the N-terminal
half of the protein (residues 1–37) and that decreased lytic or
fusogenic activities were associated with altered surface
properties of the peptide. The N-terminal segment (residues
1–9), which played little or no role in membrane fusion or
lysis, appeared to be critical for the surface-tension-reducing
properties of SP-B: Substitutions in the N-terminal segment
(tryptophan 9 or prolines 2, 4, and 6) critically inhibited the
surface activity without affecting liposome fusion or lysis. In
this work, we have analyzed the role of the N-terminal motif
in the formation and maintenance of surface-active ﬁlms
subjected to dynamic compression-expansion cycling.
MATERIALS AND METHODS
Materials
Chloroform and methanol were HPLC-grade solvents from Scharlau
(Barcelona, Spain). Phospholipids 1,2-dipalmitoyl-sn-glycero-3-phospho-
choline (DPPC) and 1-palmitoyl-2-oleoylphosphatidylglycerol (POPG) were
from Avanti Polar Lipids (Birmingham, AL). Synthetic peptides were
designed to mimic the native sequence or two variants of the N-terminal half
of SP-B (residues 1–37) (Fig. 1), which contains most determinants for SP-
B-promoted membrane-perturbation and surface activity (20). The peptides
were synthesized by Biosynthesis (Lewisville, TX) by F-moc chemistry and
puriﬁed to .95% homogeneity by HPLC. Peptide composition was con-
ﬁrmed by mass spectrometry. All other reagents and chemicals were pur-
chased from Merck (Darmstadt, Germany).
Circular dichroism
Far-UV circular dichroism (CD) spectra were recorded as previously de-
scribed (21) in a Jasco 715 spectropolarimeter equipped with a Xenon lamp.
All spectra were recorded in a 0.2-mL thermostated quartz cell with an
optical path length of 0.1 cm. Molar ellipticity was calculated taking 110 as
the mean molecular weight per residue. Estimation of the secondary struc-
ture content from the CD measurements was performed after deconvolution
of the experimental spectra into four simple components (a-helix, b-sheet,
turns, and random coil) using the CDPro software package containing three
commonly used programs: SELCON3, CONTIN/LL, and CDSSTR (22,23).
This software allows the use of different sets of proteins, including mem-
brane proteins (SMP50), to increase the reliability of the analysis in the case
of the membrane-interacting SP-B peptides.
Intrinsic ﬂuorescence of SP-B synthetic peptides
Tryptophan ﬂuorescence emission spectra of SP-B synthetic peptides in
methanol were recorded in a SLM-Aminco AB-2 spectroﬂuorimeter at
25C. Peptide concentration was 10 mg/mL. Excitation wavelength was set
at 275 or 290 nm, and emission spectra were measured over the range of
290–430 nm. Both excitation and emission slits were set at 4 nm and the cell
path was 0.2 cm. The contribution of tyrosine to the emission spectra was
calculated, as described elsewhere (24), by subtracting from the emission
spectra measured exciting at 275 nm, the emission spectra obtained exciting
at 290 nmmultiplied by a normalizing factor. This factor is the ratio between
the ﬂuorescence intensities measured using excitation at 275 nm and 290 nm,
respectively, at emission wavelengths higher than 380 nm, where no Tyr
contribution is expected.
Interfacial adsorption of peptides
Interfacial adsorption of SP-B synthetic peptides was assayed using a spe-
cially designed surface balance previously described (25). The microbalance
was ﬁlled with 1.5 mL of buffer (Tris 5 mM, NaCl 150 mM, pH 7) and, after
5-min equilibration, 10 mL of methanol containing different amounts of SP-
B synthetic peptides was injected into the subphase. Changes in surface
pressure (p) were then monitored over time. The subphase was continuously
stirred and the trough was thermostated at 25C. Subphases were prepared
with double-distilled water (the second distillation performed in the presence
of potassium permanganate). Injection of equivalent volumes of pure
methanol did not produce any detectable change in surface pressure.
Insertion of peptides into preformed monolayers
Insertion of SP-B synthetic peptides into phospholipid monolayers, pre-
formed at different initial surface pressures (pi), was followed (using the
same microbalance) by monitoring changes in surface pressure (Dp) over
time, after peptide injection into the subphase (Tris 5 mM, NaCl 150 mM,
pH7). Subphases were prepared with double-distilled water (the second
FIGURE 1 SequenceofSP-B-derivedpeptides.Amino-acid sequenceof humanSP-Band theSP-B-derived synthetic peptides studied in thiswork. Shadedboxes
represent proposed helical regions, and black lines the predicted interhelical loops derived byﬁtting the sequence of theSP-Bmature peptide to the three-dimensional
structure of NK-lysin (9). Amino-acid substitutions in the variant synthetic peptides appear shaded. Note that the exact boundaries of these domains remain unclear.
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distillation performed in the presence of potassium permanganate). Phos-
pholipid monolayers were preformed by spreading a concentrated solution
of the lipids (DPPC/POPG, 7:3, w/w) in chloroform/methanol (3:1, v/v) on
top of the aqueous surface. After 10-min stabilization, 4 mL (1 mg/mL) of
peptide in methanol were injected into the subphase. The highest increment
in surface pressure (Dp) was plotted versus the initial pressure (pi), allowing
calculation of the critical insertion pressure (pc), deﬁned as the maximum p
at which the peptide can still insert. The subphase was continuously stirred
and the temperature was kept constant at 25C during the experiment.
p-A isotherms of lipid and
lipid/peptide monolayers
Monolayers of lipid (DPPC/POPG, 7:3, w/w) or lipid/peptide binary sys-
tems were made by spreading 33 mL of a concentrated lipid or lipid/peptide
solution in chloroform/methanol (3:1, v/v) at the surface of a 5 mM Tris
buffered subphase, pH 7, containing 150 mM NaCl. These monolayers were
prepared as previously described (25), in a thermostated (25C) Langmuir-
Blodgett trough (NIMA Technologies, Coventry, United Kingdom)
equipped with a ribbon barrier to minimize ﬁlm leakage during compression.
Subphases were prepared with double-distilled water (the second distillation
performed in the presence of potassium permanganate). After spreading the
sample on top of the subphase, the organic solvent was allowed to evaporate
for 10 min before starting compression. The total area of the interface was
225 cm2 and the monolayer was compressed at 65 cm2/min, while changes
in surface pressure (p), measured with a Wilhelmy dipping plate of Whatman
No. 1 paper attached to the pressure transducer, were recorded and plotted
against the area occupied per phospholipid molecule (A).
To analyze the effect of the SP-B synthetic peptides during successive
compression-expansion cycles, monolayers prepared as described above
were compressed and expanded at 65 cm2/min, up to four cycles, while
surface pressure-area (p-A) data were collected.
Statistics
Unless otherwise indicated, the results are presented as representative
experiments after repeated examination of three different samples.
RESULTS
Structure of SP-B synthetic peptides
The secondary structure of SP-B synthetic peptides in meth-
anol was analyzed by CD spectroscopy. Fig. 2 shows the far-
UV CD spectra of three SP-B synthetic peptides (N-term
Helix 1,2, W9A, and P2,4,6A) containing the amino-acid
sequence of the N-terminal half of SP-B with or without the
substitutions indicated in Fig. 1. All the spectra exhibited CD
features consistent with a mainly a-helical conformation,
including ellipticity minima at 208 and 222 nm and a marked
maximum at 195 nm. Analysis of the experimental data, using
the CDPro suite of programs (SELCON3, CONTIN/LL, and
CDSSTR) (22,23), allowed estimation of relative proportions
of different types of secondary structure. Table 1 shows that
peptide N-term Helix 1,2 contained ;45% a-helix, whereas
peptides W9A and P2,4,6A contained ;55% a-helix. The
proportion of helical structure was lower than predicted by the
model in Fig. 1, perhaps reﬂecting the higher intrinsic ﬂex-
ibility of peptides compared to the disulﬁde-linked structure of
NK-lysin or SP-B. Another possibility is that amino acids 26–
37 could adopt a b-sheet conformation in at least a fraction
of the peptide, as has been suggested with other synthetic
peptides of this region of SP-B (26). More insight into the
three-dimensional structure of the two peptides containing
tryptophan, the main residue responsible for the intrinsic
ﬂuorescence of proteins, was obtained from the ﬂuorescence
emission spectra of methanolic solutions of N-term Helix 1,2
and P2,4,6A peptides (Fig. 3). Fluorescence-emission max-
imum was centered at 335 nm in both cases, ;15 nm below
the wavelength of the maximum ﬂuorescence expected for
free tryptophan in aqueous solution (;350 nm) (27). The
contribution of Tyr to the total ﬂuorescence spectrum obtained
by excitation at 275 nm was higher in the case of P2,4,6A
peptide than in the case of the peptide with the native se-
quence, indicating that the distance and/or the orientation of
the two aromatic residues might have changed. This change
might be affecting the efﬁciency of resonance energy transfer
from the Tyr to the nearby Trp, the ﬂuorescence quenching by
other close chains, or both.
Surface properties of SP-B synthetic peptides
Previous experiments have recently analyzed the surface-
tension-reducing properties of different SP-B synthetic
FIGURE 2 Secondary structure of SP-B-derived
peptides. Far-UV CD spectra of SP-B synthetic
peptides dissolved in methanol at room temperature.
Solid lines represent the best ﬁt of the experimental
data to theoretical spectra, calculated according to the
CDSSTR analysis (22).
240 Serrano et al.
Biophysical Journal 90(1) 238–249
peptides reconstituted in DPPC/POPG (7:3, w/w) bilayers in
a captive bubble surfactometer (20). Substitution of P2,4,6 or
W9 by alanine resulted in signiﬁcantly increased minimum
surface tension (decreased maximum surface pressure) of
peptide N-term Helix 1,2 upon cycling. To assess the
importance of Trp-9 and Pro-2, -4, and -6 in the surface
activity of SP-B-derived synthetic peptides, we have per-
formed different surface experiments in Langmuir balances
where the surface pressure-area (p-A) dependencies can be
accurately measured during successive cycling of the sur-
face. Cycling rates performed in a Langmuir balance are
typically much slower than those occurring during normal
respiration but provide detailed information on ﬁlm pro-
perties including dynamic surface-tension-lowering, re-
spreading, compressibility, and hysteresis, allowing a more
complete assessment of the surface-active behavior. We ﬁrst
tested the ability of the three SP-B synthetic peptides to
adsorb spontaneously to an open air-liquid interface when
injected into the buffered aqueous subphase from a meth-
anolic solution (Fig. 4). A rapid increase in surface pressure
after peptide injection indicates spontaneous adsorption of
the peptide into the interface, as a result of its amphipathic
structure. The maximum surface pressure measured in ad-
sorbed peptide monolayers was ;30 mN/m. This maximum
pressure was achieved with peptide concentrations of 0.5mM
or higher. Notably, the adsorption rate of the W9A peptide
was signiﬁcantly slower than that of the other two peptides,
which adsorbed almost instantaneously. Fig. 4 d represents
the increase in pressure (P1min) achieved by different peptide
concentrations 1 min after injection into the subphase. At
these short times, both peptides W9A and P2,4,6A produce
substantially lower pressures than the nativelike peptide.
Adsorption of peptide W9A requires longer times while
peptide P2,4,6A adsorbs apparently as fast as the nativelike
sequence, but with an interfacial disposition associated with
lower lateral pressures. Fig. 4 e plots the ﬁnal increase in
pressure (Dp20min) reached 20 min after peptide injection.
This plot shows how, independently of the adsorption rate,
the pressures ﬁnally achieved by peptide P2,4,6A are lower
than those produced by similar concentrations of the other
two peptides, at least for peptide concentrations lower than
0.5 mM in the subphase. Peptide P2,4,6A therefore seems to
adopt a different disposition at the interface than the wild-
type sequence or the W9A variant.
Peptides N-term Helix 1,2, W9A, and P2,4,6A were also
able to perturb and insert into an interface already occupied
by a DPPC/POPG (7:3, w/w) monolayer prepared at dif-
ferent initial surface pressures (pi). In these experiments, the
peptides were injected into the subphase underneath a
phospholipid monolayer preformed at the interface. Fig. 5
illustrates that injection of any of the three peptides into the
subphase underneath the DPPC/POPG monolayer promoted
a pressure increase (Dp) as a consequence of the association
of the peptide with the interfacial ﬁlm. The observed Dp
indicated association with, and eventual insertion of, the
peptide into the monolayer. Again, the rate of adsorption/
insertion of peptide W9A into the phospholipid ﬁlm was
always markedly lower than that of the native sequence or
that of the peptide P2,4,6A. In Fig. 6, the increase in surface
pressure (Dp) after injection of a given amount of each
peptide has been plotted versus the initial surface pressure of
the preexisting phospholipid monolayer (pi). The value Dp
always decreased with increasing pi for all peptides, as
would be expected if tighter lipid packing prevents insertion.
From these plots one can calculate the critical insertion
pressure (pc), deﬁned as the maximum pressure at which the
peptides are still able to insert. This parameter depends on
the monolayer composition as well as on the relative afﬁnity
of the peptides to associate with the interface ﬁlm. It is
generally assumed that the lateral packing in a lipid bilayer
can be roughly mimicked by a monolayer compressed to
;30 mN/m. Therefore, molecules with pc values higher than
30 mN/m are generally considered as competent to interact
FIGURE 3 Fluorescence of SP-B-derived peptides. Fluorescence emis-
sion spectra of SP-B synthetic peptides in methanolic solution. The spectra
were obtained upon excitation at 275 nm (bold line) and 290 nm (dashed
line). The spectra obtained upon excitation at 290 nm have been normalized
to determine the contribution of Trp to the total ﬂuorescence spectra
obtained by excitation at 275 nm. The contribution of Tyr (dotted line) was
calculated by subtraction of Trp contribution from the total spectrum in each
case, as described in Materials and Methods. Peptide concentration was
10 mg/mL.
TABLE 1 Secondary structure of SP-B synthetic peptides in
methanol, estimated from their far-UV CD spectra
Percentage of secondary structure
a-Helix b-Sheet b-Turns Random
N-term Helix 1,2 44 6 7 11 6 4 22 6 3 23 6 7
W9A 54 6 5 6 6 5 21 6 6 19 6 4
P2,4,6A 57 6 6 8 6 4 19 6 3 16 6 6
Note that results are expressed as means 6 SD of the estimated values
resulting from the analysis of the CD data with three different programs
(SELCON 3, CDSSTR, and CONTIN/LL).
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with and insert into lipid membranes (28). The three SP-B
synthetic peptides showed pc values higher than 30 mN/m,
as expected from their ability to perturb lipid bilayers by
promoting membrane fusion and lysis (20). The critical
pressures calculated for the two substituted variants (40.3
mN/m for W9A and 38.2 mN/m for P2,4,6A) were higher
than the pc obtained for the native sequence (35.4 mN/m).
It is possible that passage through the aqueous hypophase
could produce differences in conformation or aggregation
state of the peptides that could have consequences in the
mode of interaction/insertion with the interfacial monolayer.
Potential differences arising from transient exposure of the
peptides to a polar environment can be avoided by ﬁrst mix-
ing lipids and peptide in organic solvents and then spreading
the monolayer. Films prepared this way were used to obtain
the compression isotherms presented in Fig. 7. The p-A
isotherms of DPPC/POPG monolayers are progressively
more expanded in the presence of increasing amounts of
peptides, indicating that the peptides are also occupying a
fraction of the interface. This expansion appears to be greater
for the N-term Helix 1,2 peptide than for the two substituted
sequences, suggesting that either the native peptide inserted
FIGURE 4 Interfacial adsorption of SP-B-derived peptides. (a–c) Interfacial adsorption kinetics of SP-B synthetic peptides to a clean air-liquid interface
from a buffered subphase (5 mM Tris pH 7, containing 150 mM NaCl). After 5-min equilibration, 10 mL of methanol containing the indicated amounts of
peptides (in mg) were injected into the subphase and changes in surface pressure were monitored. The experiments were run at 25C with continuous stirring of
the subphase. Control experiments, performed by injecting the same volume of methanol in the absence of peptide, indicated no signiﬁcant changes in surface
pressure (not shown). (d,e) Increment of surface pressure 1 min (d) or 20 min (e) after injection of the different peptides into the subphase, plotted versus
peptide concentration.
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into monolayers occupying larger areas, or the number of
inserted molecules of this peptide, was higher than the
number of molecules of W9A or P2,4,6A peptides. All the
three peptides were squeezed-out from the interface at a
similar surface pressure, ;50 mN/m, as shown by the con-
vergence of lipid/peptide isotherms with isotherm of pure
lipid. Similar squeeze-out pressures have been previously
determined for native SP-B puriﬁed from animal lungs (29).
No additional displacement of the lipid/peptide isotherms
was observed beyond the pure lipid isotherm at the highest
pressures, indicating that exclusion of the peptide is not
accompanied by lipid exclusion. Interestingly, the isotherms
of ﬁlms containing the P2,4,6A peptide present a less
marked, if any, squeeze-out plateau than the isotherms of the
other two sequences. This fact also suggests that the struc-
tural motif more directly involved in the association of this
peptide with the interface might have changed as a conse-
quence of Pro substitutions. Peptide P2,4,6A penetrates into
the interfacial phospholipid ﬁlm to a lesser extent, producing
a much more limited expansion of the isotherm. At pressures
higher than the squeeze-out pressure, isotherms of mono-
layers containing N-term Helix 1,2 or P2,4,6A peptides do
not converge completely, indicating that some peptide
remains in the compressed ﬁlm whereas the W9A peptide
seems completely excluded. Again, it seems that the pres-
ence of Trp could be the reason for a stronger interaction of
N-term Helix 1,2 and P2,4,6A peptides with the interfacial
ﬁlm, resulting in partial retention at higher surface pressures.
Although the calculated pc values suggested that the Trp-
containing peptides might be excluded at lower pressures,
their high afﬁnity for the interface probably resulted in
incomplete removal during rapid compression beyond pc.
This property may also affect the stability of ﬁlms under-
going compression-expansion cycling. To test this hypoth-
esis, we subjected DPPC/POPG monolayers to several
cycles of compression and expansion in the absence or
presence of different concentrations of peptides (Fig. 8). In
the absence of peptide, only the ﬁrst compression isotherm
reached the highest surface pressure (;70 mN/m), suggest-
ing that the material lost from the compressed phase failed to
respread during the subsequent expansion period. In con-
trast, in the presence of any of the three SP-B synthetic
peptides, the isotherms reached the highest pressures even
after four compression-expansion cycles. As expected, pep-
tides signiﬁcantly improved the stability of the ﬁlm, leading
to reproducible curves after several cycles. However, the
most interesting feature of isotherms of peptide-containing
ﬁlms may be the presence of conspicuous reinsertion pla-
teaus detected during the expansion periods of the isotherms.
These small plateaus, where little change in surface pressure
was measured during expansion of the ﬁlm, are indicative
of cooperative reinsertion of surface material previously
excluded from the interface. In this context, the isotherms of
ﬁlms containing the peptide with native sequence present
much larger reinsertion plateaus than the ﬁlms containing the
two other sequences. This suggests that, at the speed used for
expansion (still signiﬁcantly lower than that imposed by
breathing or that employed in the captive bubble surfac-
tometer), N-term Helix 1,2 peptide promoted more efﬁcient
reinsertion of material into the interface than W9A or
P2,4,6A peptides. We conclude that in addition to peptide
afﬁnity for interfaces and peptide stability in compressed
phases, the rate of the peptide-promoted reinsertion during
FIGURE 6 Critical pressure for insertion of SP-B-
derived peptides in phospholipid ﬁlms. Increment of
surface pressure (Dp) observed in preformed DPPC/
POPG (7:3, w/w) monolayers measured 20 min after
injection of SP-B synthetic peptides (4 mg) into the
subphase, plotted versus the initial surface pressure
of the ﬁlms (pi). The critical insertion pressure (pc)
was calculated by extrapolation of the plot at Dp ¼
0 mN/m.
FIGURE 5 Insertion of SP-B-derived peptides into phospholipid mono-
layers. Representative insertion kinetics experiments of SP-B synthetic
peptides injected underneath phospholipid monolayers preformed at dif-
ferent initial surface pressures (pi). (Solid line, N-term Helix 1,2, pi ¼ 19
mN/m; dotted line, W9A, pi ¼ 6 mN/m; and dashed line, P2,4,6A, pi ¼ 9
mN/m.) The trough was thermostated at 25C and the subphase was
composed of 5 mM Tris buffer pH 7, containing NaCl 150 mM.
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cycling is also a property of critical importance for efﬁcient
surface-ﬁlm dynamics.
DISCUSSION
Surfactant protein SP-B is a very hydrophobic protein, with
an intrinsic amphipathic structure and high capacity for lipid
binding. In vitro, SP-B is able to perturb phospholipid vesi-
cles causing lipid mixing, fusion, and lysis (16,18,30,31).
It has been also suggested that SP-B may cross-link
phospholipid bilayers or bilayers to monolayers (32). These
properties may be involved in many of the structural
rearrangements of surfactant lipids within the biosynthetic
pathway of the type II cell (33) and after secretion of
surfactant into the extracellular alveolar airspaces (1,15,
34–36). SP-B plays an essential role in the formation and
maintenance of the interfacial ﬁlm that reduces surface
tension and prevents alveolar collapse at end expiration. This
FIGURE 7 Effect of SP-B-derived peptides on the
p-A isotherms of lipid/peptide ﬁlms. Compression iso-
therms of DPPC/POPG (7:3, w/w) monolayers in the
absence or presence of the indicated concentrations of
SP-B synthetic peptides (% P/L, w/w).
FIGURE 8 Effect of SP-B-derived peptides on cyclic compression-expansion p-A isotherms of lipid and lipid/peptide ﬁlms. Compression-expansion cyclic
isotherm of DPPC/POPG (7:3, w/w) monolayers in the absence (left panel) or in the presence (right panels) of the indicated concentrations of SP-B synthetic
peptides (% P/L, w/w). Films were formed by spreading chloroform/methanol solutions of lipid or lipid and peptide on top of the buffered subphase (Tris 5 mM
and NaCl 150 mM, pH 7). After 10-min equilibration, monolayers were compressed and expanded up to four cycles (numbered 1–4), at 25C, and the changes
in surface pressure were registered versus area/phospholipid molecule. Thin arrows indicate the direction at the beginning of the compression and expansion
periods. Thick arrows show the regions of the isotherms where reinsertion of material into the monolayer was detected during expansion.
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is likely the main reason why SP-B-deﬁcient infants develop
fatal respiratory failure shortly after birth (2,37,38). Main-
tenance of a stable surface ﬁlm is essential for respiration and
requires efﬁcient transfer of phospholipids between the ex-
tracellular large aggregate surfactant pool and the air-liquid
interface. This process involves rapid insertion of phospho-
lipids into the expanding ﬁlm during inhalation followed by
tight phospholipid packing and partial exclusion from the
compressed ﬁlm during exhalation. SP-B (as well as SP-C)
promotes adsorption of phospholipids from vesicles in the
aqueous subphase into the air-liquid interface in vitro (29),
but the mechanism by which SP-B promotes bilayer-
monolayer transitions, and the structural determinants required
to achieve this function, are not understood (1,15,36). Recent
studies suggest that the hydrophobic surfactant proteins may
accelerate adsorption by acting as catalysts that stabilize a
high-energy intermediate structure between bilayers and the
interfacial ﬁlm (39,40).
A recent study designed to map essential functional motifs
in the sequence of SP-B (20) revealed that a synthetic peptide
comprised of amino acids 1–37 of SP-B was able to repro-
duce reasonably well the fusogenic, lytic, and surface acti-
vities of the mature protein. Interestingly, several studies
have characterized lipid-protein interactions and surface
activity of a peptide from the N-terminal region of SP-B, SP-
B (1–25), which mimics many of the biophysical activities of
mature SP-B both in vitro (41–44) and in vivo (45). The
study by Ryan et al. (20) also showed that the N-terminal tail
(residues 1–9) of SP-B is particularly critical for the surface-
tension-reducing properties of the protein. For instance,
substitution of W9 or Pro-2, -4, and -6, resulted in signiﬁcant
reduction of surface activity without affecting fusogenic or
lytic properties. The goal of this study was to determine
the structural and functional implications of these two
N-terminal motifs, in terms of surface activity.
Table 2 summarizes the different features of the three SP-
B peptides with respect to their interfacial properties. The
optimal properties of N-term Helix 1,2 (the wild-type-like
peptide) indicate that, apart from the ability to perturb the
lipid packing of bilayers and monolayers, the capacity to
produce very low surface tension upon repetitive compres-
sion-expansion cycling requires 1), a very high afﬁnity for
the interface; and 2), stable association with the ﬁlm after
compression at relatively high pressure. Very high afﬁnity
for the interface is required to rapidly insert the SP-B peptide
into the surface ﬁlm during the brief expansion interlude.
The ability to penetrate/perturb ﬁlms compressed to pres-
sures higher than 40–45 mN/m is probably required for SP-B
to promote insertion of phospholipids into the surface ﬁlm,
which probably never gets pressures lower than 45 mN/m in
vivo, at the end of inspiration. The ability of the native
sequence to sustain pressures within this range may permit
a fraction of the protein to remain stably associated with the
interface at the highest pressures (lowest tensions).
Substitution of prolines or tryptophan in the N-terminal
segment of SP-B likely produces some structural change in
the peptide. The N-terminal segment of SP-B contains an
a-helical segment (presumably Helix 1), comprising residues
8–22, in membrane environments, with residues 1–8 forming
ab-sheet-likemotif (46). PeptidesW9A and P2,4,6A variants
show increased a-helical content (estimated in Table 1),
presumably byN-terminal extension or further stabilization of
Helix 1. This conformational rearrangement probably affects
the spatial orientation of the N-terminal segment (residues
1–9) with respect to Helix 1, including the relative oriented
exposure of aromatic residues Tyr-7 and Trp-9. The modiﬁed
contribution of Tyr to the ﬂuorescence emission spectra of
peptide P2,4,6A would be consistent with such an alteration.
The substitution of tryptophan at position 9 by alanine in
peptide W9A resulted in a signiﬁcant decrease in the rate of
adsorption/insertion of the peptide into the expanding
interface. Tryptophan residues are known to have a high
tendency to locate at membrane interfaces and are among the
residues with more favorable free energy to partition into
hydrophobic/hydrophilic interfaces (47). The absence of
TABLE 2 Summary of surface activities of SP-B
derived peptides
N-Term
Helix 1,2 W9A P2,4,6A
Rapid absorption to open interfaces 111 — 11
Insertion into preformed phospholipid ﬁlms 111 11 111
Expansion of lipid/peptide isotherms 111 11 —
Stable association with compressed ﬁlms
beyond squeeze-out pressure
111 — 1
Promotion of rapid reinsertion of material
during expansion
111 1 11
FIGURE 9 Proﬁle of hydrophobicity-at-interface of SP-B-derived pep-
tides. Hydropathy plot of the sequence of SP-B synthetic peptides calculated
using the hydrophobic-at-interface scale proposed by Wimley and White
(47), where the free energy of transfer of different segments of the protein
from a phospholipid bilayer into a water phase is plotted against its position
in the sequence. N-term Helix 1,2 (solid line), W9A (dotted line), and
P2,4,6A (dashed line).
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Trp-9 may therefore affect the propensity of the peptide to
adsorb to the air-liquid interface. As a consequence, the
peptide is likely progressively lost during successive com-
pression-expansion cycles and the ability to replace lipid
molecules excluded from the compressed ﬁlm is diminished.
Moreover, at surface pressures higher than 50 mN/m, the
W9A peptide was completely excluded from the interface
while N-term Helix 1,2 remained partially attached to it,
similar to native SP-B (48,49). These results support the
hypothesis that Trp-9 increases the afﬁnity of the peptide for
the interface, promotes rapid insertion between phospholipid
acyl chains, and stabilizes association with the ﬁlm at high
surface pressures. Previous ﬂuorescence quenching studies
indicated that only residues Tyr-7 to Trp-9 in the N-terminal
tail of SP-B are fully embedded in the membrane (50). Fig. 9
shows that this is in fact the region within the ﬁrst half of the
FIGURE 10 Model for the potential molecular mechanisms implied in surface activity of SP-B-derived peptides. Mechanisms potentially implicated in
surface activity of peptide N-term Helix 1,2 are depicted in the central scheme. Helix 1 is the main motif that perturbs lipid packing in phospholipid bilayers,
but requires the presence of the N-terminal tail (residues 1–9) to insert into and perturb compressed interfacial ﬁlms. Helix/b2 is a protein-protein interacting
motif that facilitates peptide-mediated bilayer-monolayer contacts. Through these contacts, concerted perturbations introduced into both the bilayers (via Helix
1 plus N-terminal tail) and the interfacial ﬁlm (with the essential participation of the N-terminal tail) would produce efﬁcient transfer of phospholipids into the
interface. Compression to the highest pressures (at end expiration) partially excludes the N-terminal tail from interface, followed by reinsertion upon expansion
(at inspiration) promoting coinsertion and reextension of associated lipids. Peptide W9A (top scheme) would have lower adsorption kinetics producing
inefﬁcient interfacial adsorption and reinsertion during expansion. Proline substitution in peptide P2,4,6A (bottom scheme) produces a conformational change
that extends Helix 1 and eliminates the N-terminal tail motif. Without this motif, the peptide is not able to sufﬁciently perturb the packing of interfacial ﬁlms
and promote lipid insertion.
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SP-B protein that possesses the highest interfacial hydro-
phobicity. Fig. 9 also illustrates how substitution of Trp-9 by
Ala substantially changes the hydropathy proﬁle of the se-
quence, decreasing the propensity of theN-terminal end of the
sequence to partition into membrane interfaces.
The failure of peptide P2,4,6A to generate high surface
pressures (lowest tensions) during successive compression-
expansion cycling may be related to the diminished ability of
this peptide to expand a phospholipid ﬁlm beyond a certain
pressure. This feature is probably related to the conforma-
tional change resulting from the substitution of prolines. We
speculate that the absence of the helix-breaking prolines
promotes a reorientation of the N-terminal segment with
respect to the main axis of amphipathic Helix 1, which is
constrained to follow the membrane plane. This change in
orientation probably produces a slight change in the envi-
ronment of the aromatic residues, Trp-9 and Tyr-7. This
hypothesis has been already proposed by others based on
topographical studies of a smaller SP-B-derived synthetic
peptide, SP-B1-25 (50). Peptide P2,4,6A showed relatively
rapid adsorption to the interface, likely as a consequence of
the presence of the two aromatic residues, but once there,
penetrated into the interface to a lesser extent than proline-
containing sequences. As illustrated in the scheme depicted
in Fig. 10, the parallel disposition of amphipathic Helix 1 at
the polar surface of the phospholipid ﬁlm probably imposes
restrictions on the orientation of the N-terminal tail (residues
1–9). Prolines 2, 4, and 6 would promote proper orientation
of aromatic residues that penetrate into the interface and
produce an important increase in surface pressure. Penetra-
tion of the peptide into the hydrophobic interfacial region
might be important to provide enough packing distortion for
the ﬁlm to accommodate new lipid molecules during inter-
facial adsorption or reinsertion. A similar model was recently
proposed by Wang and co-workers (50), who suggested that
the orientation of the N-terminal prolines in the membrane
might be inﬂuenced by the conformation of the next few
residues before the a-helix, Tyr-7, Cys-8, and Trp-9.
According to their theoretical analysis, if these residues
adopt a a-helical conformation, the side chain of Trp-9
would be exposed to the solvent instead of fully embedded in
the phospholipid membrane. In this case, interaction of the
peptide with phospholipids would likely be impaired and
surface activity decreased.
Fig. 10 integrates the current ﬁndings into a model that
illustrates how the structure of SP-Bmight facilitate the surface-
tension-reducing properties of the peptide. We have pre-
viously shown that the N-terminal half of the protein,
including residues 1–37, contains all the determinants re-
quired to promote fusion and lysis of membranes as well as
to produce and sustain very low surface tensions (20). The
importance of the N-terminal region for the function of SP-B
has been suggested by other authors (20,41–44,50,51). We
speculate that this domain contains most of the membrane-
interacting motifs in SP-B, whereas the C-terminal half could
perhaps be involved instead in protein-protein interactions,
either within the native SP-B dimer or within higher-order
oligomers. Helix 1 contains the main membrane-perturbing
motif, and its ability to perturb lipid packing in surfactant
bilayers is probably required to extract lipid molecules from
subphase membranes for insertion into the air-liquid in-
terface. Saposins, a family of proteins structurally homolo-
gous to SP-B (9), have a similar activity, i.e., extracting lipid
molecules—in this case sphingolipids—from membranes to
facilitate their catalysis by sphingolipidases. In the case of
SP-B, phospholipid molecules extracted from surfactant
bilayers would be targeted to the interfacial ﬁlm. We have
proposed that the motif we previously termed Helix 2 could
promote peptide-peptide interactions that bring into close
proximity two bilayers (required for SP-B to catalyze lipid
exchange or fusion between vesicles) or a bilayer and the
interfacial monolayer (to catalyze interfacial adsorption or
reinsertion) (20). Consistent with this model, only peptides
containing the Helix 2 motif, produced agglutination of both
Gram1 and Gram bacteria (unpublished data). A study by
Flach et al. (26), of the structure of a SP-B peptide (9–36) in
methanol, assigned an antiparallel b-sheet conformation to
the segment 26–32. Such b-sheet conformation would con-
tradict the model proposed in Fig. 1. One possibility is that
peptide 1–37, as the 9–36 peptide studied by Flach et al. (26),
might have a tendency to fold into b-sheet instead of a-helix
when it is isolated from the structural context of the whole
protein. This tendency could promote peptide-peptide inter-
actions that mediate peptide self-association and bilayer-
bilayer or bilayer-monolayer apposition. Interestingly, peptide
SP-B (1–25), which lacks the Helix 2 motif, signiﬁcantly
improved surface properties when it is synthesized as a
dimeric form (52). Adoption of b-sheet instead of a-helical
conformation in at least a fraction of the peptides could also
explain the proportion of secondary structure determined for
the different peptide variants in methanol (in Table 1). On the
other hand, Helix 1 alone would not be sufﬁcient to insert
into and perturb interfacial phospholipid ﬁlms at surface
pressures higher than those existing in free standing bilayers
(;30 mN/m). The results of this work suggest that the
N-terminal tail of SP-B has been specially optimized to insert
rapidly into and maintain association with highly packed
surface ﬁlms. This motif promotes very rapid and efﬁcient
insertion-exclusion-reinsertion kinetics during the respira-
tory compression-expansion cycle, and should be necessarily
considered when designing SP-B mimic peptides.
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